Great Point Partners

financial services

Venture Capital United States
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Disclosed deployed
across known amounts
Stages

About

financial services

Portfolio

No portfolio companies in this dataset yet.

Investor Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is Great Point Partners' primary sector of investment?
Great Point Partners primarily invests in the Health Tech & Life Sciences sector, with all recorded portfolio companies and investment rounds falling within this area.
Can you name a notable portfolio company of Great Point Partners and its investment details?
Great Point Partners made a lead investment of $120,000,000 in UroGen Pharma in July 2023. UroGen Pharma has raised a total of $522.2M.
What was Great Point Partners' earliest recorded investment?
Great Point Partners' earliest recorded investment was in Vim in November 2016, where they participated in a round of $11,058,000.
What is the typical investment range for Great Point Partners?
Great Point Partners' investment range is between $11.06M and $120M, based on available data.
Has Great Point Partners acted as a lead investor in any of its portfolio companies?
Yes, Great Point Partners was a lead investor in UroGen Pharma in July 2023.
What funding stages has Great Point Partners participated in?
Great Point Partners has participated in A Round and PIPE funding stages.
How many new portfolio companies did Great Point Partners add in 2023?
Great Point Partners added one new portfolio company in July 2023, which was UroGen Pharma.
What is the total raised amount for Vim, a Great Point Partners portfolio company?
Vim, a Great Point Partners portfolio company, has raised a total of $88.06M.